Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$13.27
Day's range
$14.48

Contineum Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SUVRETTA CAPITAL MANAGEMENT, LLC 05/15/2026 2.84 M $37.11 M   0.00% 10.26%
JANUS HENDERSON GROUP PLC 05/18/2026 2.73 M $35.59 M   11.67% 9.87%
JOHNSON & JOHNSON 05/13/2026 1.98 M $25.85 M   0.00% 7.14%
FRANKLIN RESOURCES INC 05/13/2026 1.84 M $24.02 M   -2.14% 6.64%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 1.69 M $22.01 M   -8.53% 6.09%
MILLENNIUM MANAGEMENT LLC 05/15/2026 1.54 M $20.05 M   84.84% 5.54%
BAKER BROS. ADVISORS LP 05/15/2026 1.42 M $18.56 M   0.00% 5.13%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 1.30 M $16.93 M   -40.54% 4.68%
PERCEPTIVE ADVISORS LLC 05/29/2026 1.26 M $16.40 M   -14.27% 4.53%
05/15/2026 1.21 M $15.86 M   100.00% 4.38%
FMR LLC 05/15/2026 814.87 K $10.64 M   0.00% 2.94%
IKARIAN CAPITAL, LLC 05/15/2026 807.87 K $10.55 M   185.60% 2.92%
GREAT POINT PARTNERS LLC 05/15/2026 800.20 K $10.45 M   0.02% 2.89%
LONGAEVA PARTNERS L.P. 05/15/2026 732.09 K $9.56 M   55.76% 2.64%
SECTORAL ASSET MANAGEMENT INC 05/15/2026 727.59 K $9.50 M   -9.14% 2.63%
HHLR ADVISORS, LTD. 05/15/2026 669.34 K $8.74 M   0.00% 2.42%
BLACKROCK, INC. 05/13/2026 669.12 K $8.74 M   24.80% 2.42%
RED TREE MANAGEMENT, LLC 04/22/2026 638.16 K $8.33 M   0.00% 2.30%
VERSANT VENTURE MANAGEMENT, LLC 05/05/2026 542.63 K $7.09 M   0.00% 1.96%
05/14/2026 513.05 K $6.70 M   100.00% 1.85%
BOXER CAPITAL MANAGEMENT, LLC 05/15/2026 494.00 K $6.45 M   0.00% 1.78%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 371.64 K $4.85 M   39.84% 1.34%
CITADEL ADVISORS LLC 05/15/2026 350.20 K $4.57 M   100.00% 1.26%
GOLDMAN SACHS GROUP INC 05/15/2026 307.11 K $4.01 M   190.84% 1.11%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 301.73 K $3.94 M   -1.89% 1.09%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 282.04 K $3.69 M   31.87% 1.02%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 276.66 K $3.61 M   -0.82% 1.00%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 232.53 K $3.04 M   439.80% 0.84%
UBS GROUP AG 05/05/2026 230.41 K $3.01 M   15.56% 0.83%
MARSHALL WACE, LLP 05/15/2026 226.30 K $2.96 M   25.16% 0.82%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 222.33 K $2.90 M   206.69% 0.80%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2026 173.48 K $2.27 M   0.00% 0.63%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 153.92 K $2.01 M   100.00% 0.56%
CASDIN CAPITAL, LLC 05/15/2026 148.33 K $1.94 M   0.00% 0.54%
EVERSEPT PARTNERS, LP 05/15/2026 146.41 K $1.91 M   6.49% 0.53%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 144.01 K $1.88 M   30.84% 0.52%
05/15/2026 142.00 K $1.85 M   100.00% 0.51%
JANE STREET GROUP, LLC 05/12/2026 107.38 K $1.40 M   284.25% 0.39%
STATE STREET CORP 05/15/2026 101.28 K $1.32 M   19.96% 0.37%
VERDAD ADVISERS, LP 05/15/2026 86.03 K $1.12 M   100.00% 0.31%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 84.89 K $1.11 M   -88.82% 0.31%
MORGAN STANLEY 05/15/2026 70.80 K $924.66 K   -43.03% 0.26%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 69.40 K $906.36 K   21.54% 0.25%
NORTHERN TRUST CORP 05/14/2026 65.93 K $861.02 K   22.37% 0.24%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 59.95 K $782.10 K   100.00% 0.22%
SQUAREPOINT OPS LLC 05/15/2026 59.84 K $781.56 K   100.00% 0.22%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 55.61 K $726.25 K   100.00% 0.20%
683 CAPITAL MANAGEMENT, LLC 05/15/2026 55.00 K $718.30 K   -39.85% 0.20%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 54.07 K $703.00 K   -16.44% 0.20%
STRATEGIES WEALTH ADVISORS, LLC 05/15/2026 50.00 K $653.00 K   0.00% 0.18%

Contineum Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 102 institutional investors and hedge funds held shares of Contineum Therapeutics Inc.. The most heavily invested institutionals were:

SUVRETTA CAPITAL MANAGEMENT, LLC: 2.84 M

JANUS HENDERSON GROUP PLC: 2.73 M

JOHNSON & JOHNSON: 1.98 M

FRANKLIN RESOURCES INC: 1.84 M

BALYASNY ASSET MANAGEMENT L.P.: 1.69 M

MILLENNIUM MANAGEMENT LLC: 1.54 M

110.30% of Contineum Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 30.34 M shares in the last 24 months. This purchase volume represents approximately $410.82 M in transactions.